Back
36
Also listed as
PHGUF
OTC
Day Range
$15.56
$16.52
52-Week Range
$7.50
$21.34
Volume
73,860
50D / 200D Avg
$17.05
/
$14.62
Prev Close
$16.01
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 435.2 | 0.3 |
| P/B | 4.5 | 2.9 |
| ROE % | 1.1 | 3.7 |
| Net Margin % | 0.8 | 3.8 |
| Rev Growth 5Y % | 12.7 | 10.0 |
| D/E | 0.5 | 0.2 |
Analyst Price Target
Hold
$39.50
+147.3%
Low: $37.00
High: $42.00
Forward P/E
95.0
Forward EPS
$0.17
EPS Growth (est.)
+0.0%
Est. Revenue
410 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$0.25
$0.23 – $0.27
|
600 M | 1 |
| FY2029 |
$0.49
$0.44 – $0.53
|
440 M | 1 |
| FY2028 |
$0.18
$0.16 – $0.20
|
350 M | 1 |
Key Takeaways
Revenue grew 12.73% annually over 5 years — strong growth
ROE of 1.07% is below average
Debt/Equity of 0.49 — conservative balance sheet
Generating 41.98M in free cash flow
P/E of 435.23 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 4.68%
Growth
Revenue Growth (5Y)
12.73%
Revenue (1Y)8.05%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
1.07%
ROIC3.52%
Net Margin0.76%
Op. Margin5.13%
Safety
Debt / Equity
0.49
Current Ratio2.20
Interest Coverage0.91
Valuation
P/E Ratio
435.23
P/B Ratio4.49
EV/EBITDA63.73
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 8.05% | Revenue Growth (3Y) | 14.41% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 12.73% | Earnings Growth (5Y) | -37.54% |
| Profitability | |||
| Revenue (TTM) | 321.12M | Net Income (TTM) | 2.43M |
| ROE | 1.07% | ROA | 0.57% |
| Gross Margin | 87.90% | Operating Margin | 5.13% |
| Net Margin | 0.76% | Free Cash Flow (TTM) | 41.98M |
| ROIC | 3.52% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.49 | Current Ratio | 2.20 |
| Interest Coverage | 0.91 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 435.23 | P/B Ratio | 4.49 |
| P/S Ratio | 3.30 | PEG Ratio | -3.67 |
| EV/EBITDA | 63.73 | Dividend Yield | 0.00% |
| Market Cap | 1.06B | Enterprise Value | 1.05B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 321.12M | 297.20M | 245.32M | 205.62M | 198.87M |
| Net Income | 2.43M | -11.84M | -10.55M | 13.67M | 16.00M |
| EPS (Diluted) | 0.03 | -0.17 | -0.14 | 0.16 | 0.18 |
| Gross Profit | 282.27M | 261.80M | 220.10M | 188.06M | 177.73M |
| Operating Income | 16.49M | -8.62M | -5.39M | 18.23M | 13.56M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 425.52M | 399.99M | 462.85M | 425.80M | 397.32M |
| Total Liabilities | 189.68M | 178.92M | 244.07M | 221.16M | 204.40M |
| Shareholders' Equity | 235.84M | 221.06M | 218.78M | 204.64M | 192.92M |
| Total Debt | 115.78M | 112.31M | 171.55M | 166.69M | 161.76M |
| Cash & Equivalents | 124.32M | 54.94M | 61.74M | 207.34M | 191.92M |
| Current Assets | 254.88M | 278.44M | 316.34M | 277.50M | 249.44M |
| Current Liabilities | 115.79M | 73.80M | 77.97M | 59.70M | 46.77M |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#707 of 1052
Recent Activity
Entered
Cash Flow Compounder
Mar 24, 2026